73 related articles for article (PubMed ID: 10678356)
1. Fusogenic effects of murine retroviruses and cationic enhancers of transduction.
Xu G; Solaiman F; Zink MA; Hodgson CP
Cancer Gene Ther; 2000 Jan; 7(1):53-8. PubMed ID: 10678356
[TBL] [Abstract][Full Text] [Related]
2. Detection of osteoclastic cell-cell fusion through retroviral vector packaging.
Kondo T; Ikeda K; Matsuo K
Bone; 2004 Nov; 35(5):1120-6. PubMed ID: 15542037
[TBL] [Abstract][Full Text] [Related]
3. Characterization of R peptide of murine leukemia virus envelope glycoproteins in syncytium formation and entry.
Kubo Y; Tominaga C; Yoshii H; Kamiyama H; Mitani C; Amanuma H; Yamamoto N
Arch Virol; 2007; 152(12):2169-82. PubMed ID: 17851730
[TBL] [Abstract][Full Text] [Related]
4. Superior transduction of mouse hematopoietic stem cells with 10A1 and VSV-G pseudotyped retrovirus vectors.
Barrette S; Douglas J; Orlic D; Anderson SM; Seidel NE; Miller AD; Bodine DM
Mol Ther; 2000 Apr; 1(4):330-8. PubMed ID: 10933951
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein.
Zhang J; Frolov I; Russell SJ
J Gene Med; 2004 Oct; 6(10):1082-91. PubMed ID: 15368589
[TBL] [Abstract][Full Text] [Related]
6. Adenoviral vectors expressing fusogenic membrane glycoproteins activated via matrix metalloproteinase cleavable linkers have significant antitumor potential in the gene therapy of gliomas.
Allen C; McDonald C; Giannini C; Peng KW; Rosales G; Russell SJ; Galanis E
J Gene Med; 2004 Nov; 6(11):1216-27. PubMed ID: 15459967
[TBL] [Abstract][Full Text] [Related]
7. Two point mutations increase targeted transduction and stabilize vector association of a modified retroviral envelope protein.
Zavorotinskaya T; Albritton LM
Mol Ther; 2001 Mar; 3(3):323-8. PubMed ID: 11273774
[TBL] [Abstract][Full Text] [Related]
8. Gene transfer of human TCR in primary murine T cells is improved by pseudo-typing with amphotropic and ecotropic envelopes.
Pouw NM; Westerlaken EJ; Willemsen RA; Debets R
J Gene Med; 2007 Jul; 9(7):561-70. PubMed ID: 17471588
[TBL] [Abstract][Full Text] [Related]
9. Rescue of retroviral envelope fusion deficiencies by cationic liposomes.
Porter CD
J Gene Med; 2002; 4(6):622-33. PubMed ID: 12439854
[TBL] [Abstract][Full Text] [Related]
10. Enhanced in vitro and in vivo gene delivery using cationic agent complexed retrovirus vectors.
Themis M; Forbes SJ; Chan L; Cooper RG; Etheridge CJ; Miller AD; Hodgson HJ; Coutelle C
Gene Ther; 1998 Sep; 5(9):1180-6. PubMed ID: 9930318
[TBL] [Abstract][Full Text] [Related]
11. Generation of stable retrovirus packaging cell lines after transduction with herpes simplex virus hybrid amplicon vectors.
Sena-Esteves M; Hampl JA; Camp SM; Breakefield XO
J Gene Med; 2002; 4(3):229-39. PubMed ID: 12112640
[TBL] [Abstract][Full Text] [Related]
12. Effect of amniotic fluid on cationic lipid mediated transfection and retroviral infection.
Douar AM; Themis M; Sandig V; Friedmann T; Coutelle C
Gene Ther; 1996 Sep; 3(9):789-96. PubMed ID: 8875227
[TBL] [Abstract][Full Text] [Related]
13. Expression of PiT1 and PiT2 retroviral receptors and transduction efficiency of tumor cells.
Grabarczyk P; Wysocki PJ; Gryska K; Mackiewicz A
Acta Biochim Pol; 2002; 49(2):333-9. PubMed ID: 12362974
[TBL] [Abstract][Full Text] [Related]
14. Characterization of an alternative packaging system derived from the cat RD114 retrovirus for gene delivery.
Ghani K; Cottin S; de Campos-Lima PO; Caron MC; Caruso M
J Gene Med; 2009 Aug; 11(8):664-9. PubMed ID: 19507185
[TBL] [Abstract][Full Text] [Related]
15. Evidence for nonspecific adsorption of targeted retrovirus vector particles to cells.
Pizzato M; Blair ED; Fling M; Kopf J; Tomassetti A; Weiss RA; Takeuchi Y
Gene Ther; 2001 Jul; 8(14):1088-96. PubMed ID: 11526456
[TBL] [Abstract][Full Text] [Related]
16. Enhanced transgene expression in primitive hematopoietic progenitor cells and embryonic stem cells efficiently transduced by optimized retroviral hybrid vectors.
Ketteler R; Glaser S; Sandra O; Martens UM; Klingmüller U
Gene Ther; 2002 Apr; 9(8):477-87. PubMed ID: 11948372
[TBL] [Abstract][Full Text] [Related]
17. Viral fusogenic membrane glycoprotein expression causes syncytia formation with bioenergetic cell death: implications for gene therapy.
Higuchi H; Bronk SF; Bateman A; Harrington K; Vile RG; Gores GJ
Cancer Res; 2000 Nov; 60(22):6396-402. PubMed ID: 11103804
[TBL] [Abstract][Full Text] [Related]
18. Activation conditions determine susceptibility of murine primary T-lymphocytes to retroviral infection.
Hagani AB; Rivière I; Tan C; Krause A; Sadelain M
J Gene Med; 1999; 1(5):341-51. PubMed ID: 10738551
[TBL] [Abstract][Full Text] [Related]
19. A retroviral packaging cell line for pseudotype vectors based on glioma-infiltrating progenitor cells.
Fischer YH; Miletic H; Giroglou T; Litwak S; Stenzel W; Neumann H; von Laer D
J Gene Med; 2007 May; 9(5):335-44. PubMed ID: 17474071
[TBL] [Abstract][Full Text] [Related]
20. Small increases in pH enhance retroviral vector transduction efficiency of NIH-3T3 cells.
Jensen TW; Chen Y; Miller WM
Biotechnol Prog; 2003; 19(1):216-23. PubMed ID: 12573028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
